Belgium to use Pfizer against COVID-19, Omicron sub variants in vaccine campaign: Minister

Belgium will be among the countries using Pfizer’s vaccine against the Wuhan variant and the Omicron sub-variants BA.4 and BA.5 of the novel coronavirus in its vaccine campaign against the contagious mutants. The health minister of Belgium has finalized the following decision.

The European Medicines Agency (EMA) on Monday has given the green light for the use of the vaccine, as it had already done for the Pfizer and Moderna vaccines against the BA.1-omicron subvariant, which is already being used in the new vaccination campaign.

The Inter-ministerial Conference has also made a decision on Wednesday to accept the delivery of the vaccine against sub-variants BA.4 and BA.5, as most other European nations have done. It will be already for use in future deliveries in a few weeks, along with the 1,748,160 modified Pfizer vaccines already delivered and the 403,800 modified Moderna vaccines.

People who had already been boosted in summer with an original vaccine, such as some of the inhabitants of residential care centres, the over-80s and healthcare professionals, are again eligible for a next booster- at least three months after their last jab, with a modified vaccine.